Papers
1
Total Citations
2
H-Index
1
About
Peng Huo is a pioneering researcher in stem cell biology and regenerative medicine, with a primary focus on somatic cell reprogramming and the development of induced pluripotent stem cells (iPSCs). His most notable contribution is the development of a robotic-based spatial-restricting structured flow system for selecting monoclonal cell lineages from somatic reprogramming, a breakthrough that addresses the critical challenge of lineage heterogeneity in iPSC generation. This innovative approach, detailed in his 2024 paper, enhances the efficiency and purity of iPSC derivation, reducing the risk of lineage manipulations that compromise therapeutic applications. While his work is still emerging, with his key paper accumulating 2 citations, it holds significant promise for advancing personalized disease modeling and cell-based therapies. Huo’s research bridges bioengineering and stem cell biology, offering a scalable solution for producing high-quality seed cells for regenerative medicine. His contributions are particularly impactful for students and researchers exploring automation in cellular reprogramming, as they pave the way for more reliable and reproducible stem cell production, ultimately accelerating clinical translation in tissue repair and disease treatment.
Research Focus
Key Achievements
Top Papers
- 1